Germany Imported 218 Tons of Medical Cannabis in 2025

Import Volume Reflects Mature Medical Market

Germany's 218.4-ton import total in 2025 represents sustained growth in a medical program now serving approximately 340,000 registered patients. The Federal Institute for Drugs and Medical Devices (BfArM) oversees import licensing, with product flowing primarily from Canada, the Netherlands, and Portugal. Domestic cultivation remains limited. Fewer than six licensed German producers operate at commercial scale.

The 2025 figure compares to 194.7 tons in 2024 and 168.3 tons in 2023, according to BfArM annual summaries. Year-over-year growth has slowed from the 30-40% rates seen between 2019 and 2022, signaling market maturation rather than explosive expansion.

Canada Supplies Majority of German Imports

Canadian licensed producers accounted for an estimated 65% of Germany's 2025 cannabis imports, with Tilray, Aurora, and Canopy Growth holding the largest market shares. The Netherlands supplied roughly 20% through Bedrocan and other state-licensed growers, while Portuguese cultivators contributed 10-12% via exporters like Tilray Portugal.

Germany's reliance on imports underscores the slow rollout of domestic production licenses. BfArM awarded just three new cultivation licenses in 2024-2025, citing strict quality and security standards that have deterred many applicants.

Partial Legalization Law Didn't Trigger Import Surge

Germany's April 2024 partial legalization—allowing adult possession and social clubs—hasn't materially shifted import volumes, which remain tied to the medical program. The social-club framework prohibits commercial sales and limits member cultivation to non-traded product, leaving the medical channel as the sole regulated import pathway.

Recreational import pathways don't exist under current law. BfArM doesn't license cannabis for non-medical use, and social clubs must source from members' personal grows or from other clubs within strict nonprofit parameters.

Price Dynamics and Reimbursement Pressures

Wholesale import prices for medical cannabis in Germany averaged €3.20-€4.10 per gram in 2025, down from €5.50-€6.80 in 2021. Oversupply in Canada and increased competition from Portuguese growers drove the decline. German statutory health insurers—which reimburse approximately 70% of medical cannabis prescriptions—have pushed for lower pricing, threatening to delist higher-cost products from formularies.

Reimbursement pressure has forced several smaller Canadian exporters out of the German market. Tilray and Aurora have maintained share by cutting prices and negotiating volume contracts with major insurers.

Regulatory Comparison: Germany vs. EU Peers

Germany's 218-ton import volume dwarfs other European medical markets: the Netherlands imported 8.4 tons in 2025, Italy 6.1 tons, and Poland 4.7 tons. Only France approached German scale, importing an estimated 22 tons under its experimental medical framework launched in 2021.

That disparity reflects Germany's early-mover advantage—BfArM began licensing medical cannabis in 2017—and its population of 84 million. Per-capita consumption, however, remains lower than Canada or Israel, suggesting room for patient-base expansion if prescription barriers ease.

Outlook: Domestic Production and EU Export Ambitions

BfArM has said it will issue 5-8 additional cultivation licenses by end-2026, aiming to reduce import dependence to below 50% by 2028. German-grown cannabis would compete on freight cost and lead time, though Canadian producers retain advantages in scale and varietal selection.

Several German licensees have announced plans to export to other EU markets once domestic capacity exceeds local demand. That timeline remains uncertain—no German producer has yet achieved the 10-ton annual output threshold BfArM considers necessary for export viability.

We'll be watching whether BfArM's domestic licensing push meets its 2028 target and whether German growers can compete on price with established Canadian exporters. For comprehensive analysis of Germany's evolving cannabis framework, see the CannIntel topic hub on Germany Cannabis Legalization.